Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma.

Haque M, Li J, Huang YH, Almowaled M, Barger CJ, Karpf AR, Wang P, Chen W, Turner SD, Lai R.

Cancers (Basel). 2019 Aug 6;11(8). pii: E1119. doi: 10.3390/cancers11081119.

2.

Constitutive Activation of STAT3 in Myeloma Cells Cultured in a Three-Dimensional, Reconstructed Bone Marrow Model.

Huang YH, Molavi O, Alshareef A, Haque M, Wang Q, Chu MP, Venner CP, Sandhu I, Peters AC, Lavasanifar A, Lai R.

Cancers (Basel). 2018 Jun 16;10(6). pii: E206. doi: 10.3390/cancers10060206.

3.

The absence of a novel intron 19-retaining ALK transcript (ALK-I19) and MYCN amplification correlates with an excellent clinical outcome in neuroblastoma patients.

Alshareef A, Irwin MS, Gupta N, Zhang HF, Haque M, Findlay SD, Seong BKA, Lai J, Rayis M, Al-Dandan S, Lai R.

Oncotarget. 2018 Jan 12;9(12):10698-10713. doi: 10.18632/oncotarget.24216. eCollection 2018 Feb 13.

4.

High expression of β-catenin contributes to the crizotinib resistant phenotype in the stem-like cell population in neuroblastoma.

Alshareef A, Gupta N, Zhang HF, Wu C, Haque M, Lai R.

Sci Rep. 2017 Dec 4;7(1):16863. doi: 10.1038/s41598-017-17319-9.

5.

WSB1: from homeostasis to hypoxia.

Haque M, Kendal JK, MacIsaac RM, Demetrick DJ.

J Biomed Sci. 2016 Aug 19;23(1):61. doi: 10.1186/s12929-016-0270-3. Review.

6.

Lupoid plaque--a new morphologic variant of post-kala-azar dermal leishmaniasis.

Shrivastava SB, Haque M, Puri P.

Int J Dermatol. 2004 Jun;43(6):428-9. No abstract available.

PMID:
15186223

Supplemental Content

Loading ...
Support Center